Cargando…
Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA
OBJECTIVE: To identify a treatment-responsive BRAF(V600E) mutation in brainstem neurohistiocytosis, where no lesional tissue was readily obtainable, using a cell-free DNA approach. METHODS: Cell-free DNA was extracted from urine and allele-specific PCR for the BRAF(V600E) mutation was performed. Res...
Autores principales: | Hunt, David, Milne, Paul, Fernandes, Peter, Bigley, Venetia, Collin, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096418/ https://www.ncbi.nlm.nih.gov/pubmed/27833932 http://dx.doi.org/10.1212/NXI.0000000000000299 |
Ejemplares similares
-
Complete remission of critical neurohistiocytosis by vemurafenib
por: Euskirchen, Philipp, et al.
Publicado: (2015) -
Human dendritic cell subsets: an update
por: Collin, Matthew, et al.
Publicado: (2018) -
Haematopoietic and immune defects associated with GATA2 mutation
por: Collin, Matthew, et al.
Publicado: (2015) -
Dendritic cell analysis in primary immunodeficiency
por: Bigley, Venetia, et al.
Publicado: (2016) -
Langerin-expressing dendritic cells in human tissues are related to
CD1c(+) dendritic cells and distinct from Langerhans cells and
CD141(high) XCR1(+) dendritic cells
por: Bigley, Venetia, et al.
Publicado: (2015)